BIOMAT Database Logo BIOMAT Database Logo

Hyperprolactinemia preceding Cushing's disease. 2000

L Barbetta, and C Dall'Asta, and B Ambrosi

UI MeSH Term Description Entries
D006966 Hyperprolactinemia Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8) Prolactin Hypersecretion Syndrome,Prolactin, Inappropriate Secretion,Hyperprolactinaemia,Inappropriate Prolactin Secretion,Inappropriate Prolactin Secretion Syndrome,Hyperprolactinemias,Hypersecretion Syndrome, Prolactin,Inappropriate Secretion Prolactin,Prolactin Secretion, Inappropriate,Secretion Prolactin, Inappropriate,Secretion, Inappropriate Prolactin,Syndrome, Prolactin Hypersecretion
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

L Barbetta, and C Dall'Asta, and B Ambrosi
[Hyperprolactinemia in Cushing's disease].
January 1985, Medicina,
L Barbetta, and C Dall'Asta, and B Ambrosi
Cushing's disease preceding sarcoidosis.
June 1995, Internal medicine (Tokyo, Japan),
L Barbetta, and C Dall'Asta, and B Ambrosi
Hyperprolactinemia preceding development of autoimmune disease.
August 1996, The Journal of rheumatology,
L Barbetta, and C Dall'Asta, and B Ambrosi
Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
May 1984, The Journal of clinical endocrinology and metabolism,
L Barbetta, and C Dall'Asta, and B Ambrosi
Retrospective Analysis of Cushing's Disease with or without Hyperprolactinemia.
January 2014, International journal of endocrinology,
L Barbetta, and C Dall'Asta, and B Ambrosi
Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist.
January 2016, Internal medicine (Tokyo, Japan),
L Barbetta, and C Dall'Asta, and B Ambrosi
[A case of Cushing's disease: hallucinatory paranoid state preceding physical symptoms].
January 1994, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
L Barbetta, and C Dall'Asta, and B Ambrosi
Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
June 1991, Pathology, research and practice,
L Barbetta, and C Dall'Asta, and B Ambrosi
Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
February 1984, Journal of endocrinological investigation,
L Barbetta, and C Dall'Asta, and B Ambrosi
[Cushing's disease-Cushing's syndrome].
March 1960, Orvosi hetilap,
Copied contents to your clipboard!